Variation in commercial prices for thyroidectomy and parathyroidectomy at US hospitals.

IF 2.7 3区 医学 Q1 SURGERY
Samuel J Enumah, David C Chang, Nancy L Cho, Carrie E Cunningham, Gerard M Doherty, Matthew A Nehs, Gregory W Randolph, Jason B Liu
{"title":"Variation in commercial prices for thyroidectomy and parathyroidectomy at US hospitals.","authors":"Samuel J Enumah, David C Chang, Nancy L Cho, Carrie E Cunningham, Gerard M Doherty, Matthew A Nehs, Gregory W Randolph, Jason B Liu","doi":"10.1016/j.amjsurg.2024.116072","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The 2021 Hospital Price Transparency Rule mandated hospitals to publicly disclose their service prices to improve competition and lower healthcare costs. Our aim was to characterize commercial price variation for thyroidectomy and parathyroidectomy.</p><p><strong>Methods: </strong>We performed a national cross-sectional study of hospital price variation in 2022 and 2023 using the Turquoise Health dataset. Our main outcomes were within- and across-hospital 90th-to-10th percentile commercial price ratios and a high commercial-to-Medicare (1.5) price ratio. We performed logistic regressions to identify hospital factors associated with a high commercial-to-Medicare price ratio.</p><p><strong>Results: </strong>For 16,794 unique commercial rates across 564 facilities, within-hospital price ratios ranged from 2.0 to 2.4, and across-hospital price ratios ranged from 2.7 to 4.1. High market concentration and five-star hospital rating were associated with high commercial-to-Medicare price ratios compared to low market concentration and three-star hospital rating, respectively.</p><p><strong>Conclusions: </strong>Notable variation exists within and across hospitals signaling facilities have negotiated different payments from insurance companies for the same service. Quality may be a modifiable factor to increase hospital revenue and improve care for patients.</p>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"241 ","pages":"116072"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjsurg.2024.116072","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The 2021 Hospital Price Transparency Rule mandated hospitals to publicly disclose their service prices to improve competition and lower healthcare costs. Our aim was to characterize commercial price variation for thyroidectomy and parathyroidectomy.

Methods: We performed a national cross-sectional study of hospital price variation in 2022 and 2023 using the Turquoise Health dataset. Our main outcomes were within- and across-hospital 90th-to-10th percentile commercial price ratios and a high commercial-to-Medicare (1.5) price ratio. We performed logistic regressions to identify hospital factors associated with a high commercial-to-Medicare price ratio.

Results: For 16,794 unique commercial rates across 564 facilities, within-hospital price ratios ranged from 2.0 to 2.4, and across-hospital price ratios ranged from 2.7 to 4.1. High market concentration and five-star hospital rating were associated with high commercial-to-Medicare price ratios compared to low market concentration and three-star hospital rating, respectively.

Conclusions: Notable variation exists within and across hospitals signaling facilities have negotiated different payments from insurance companies for the same service. Quality may be a modifiable factor to increase hospital revenue and improve care for patients.

美国医院甲状腺切除术和甲状旁腺切除术的商业价格差异。
背景:2021 年《医院价格透明规则》规定,医院必须公开披露其服务价格,以促进竞争并降低医疗成本。我们的目的是描述甲状腺切除术和甲状旁腺切除术的商业价格变化:我们使用 Turquoise Health 数据集对 2022 年和 2023 年的医院价格变化进行了全国横断面研究。我们的主要结果是医院内和医院间第 90 个百分点到第 10 个百分点的商业价格比,以及高商业与医保(1.5)价格比。我们进行了逻辑回归,以确定与高商业与医保价格比相关的医院因素:结果:在 564 家医院的 16,794 个不同的商业价格中,医院内价格比在 2.0 到 2.4 之间,医院间价格比在 2.7 到 4.1 之间。与低市场集中度和三星级医院相比,高市场集中度和五星级医院评级分别与高商业与医保价格比率相关:结论:医院内部和医院之间存在显著差异,这表明医院就相同的服务与保险公司协商了不同的支付方式。质量可能是增加医院收入和改善患者护理的一个可调节因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.00
自引率
6.70%
发文量
570
审稿时长
56 days
期刊介绍: The American Journal of Surgery® is a peer-reviewed journal designed for the general surgeon who performs abdominal, cancer, vascular, head and neck, breast, colorectal, and other forms of surgery. AJS is the official journal of 7 major surgical societies* and publishes their official papers as well as independently submitted clinical studies, editorials, reviews, brief reports, correspondence and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信